CME stock: buy or sell?
September 20th, 2019
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
Should I buy CME stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, CME stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is CME stock a buy?
Financial institutions and banks publish stock ratings everyday.At Stocks2.com, we detected 15 ratings published for CME stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-7-3||Wells Fargo & Co||n/a||Market Perform|
|2019-7-3||Wells Fargo & Co||n/a||Market Perform|
|2019-3-22||JPMorgan Chase & Co.||n/a||Underweight|
|2019-2-15||Sanford C. Bernstein||n/a||Outperform|
|2019-2-15||JPMorgan Chase & Co.||Neutral||Underweight|
CME stock analysis
Shares of CME closed today at $211.15 and depreciated an unpleasant -0.38%.
CME closed today at $211.15 and depreciated an unpleasant -0.38%. Since SMA100d and SMA200d crossed up on July, CME price climbed $17.69 per share (9.14%). On May CME price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On Sep/6, CME hit new all time highs, pushing higher previous ATH of $224.10 recorded on Sep 5th. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
After sliding a dreadful -8.03% in a week last week, CME closed this week at $211.15 and soared a nice 2.60%.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $224.15 resistance. Not so far away is the last price record CME marked early September. Early July, SMA20w and SMA40w crossed up triggering a rise of 9.14%. Early May CME price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
CME stock price history
CME stock went public on December 6th, 2002 with a price of $4.851. Since then, CME stock grew a 4,253.60%, with an average of 265.90% per year. If you had invested $1,000 in CME stock in 2002, it would worth $42,536.00 today.
1: Adjusted price after possible price splits or reverse-splits.
CME stock historical price chart
CME stock reached all-time highs on Sep 6th with a price of $224.15.
CME stock price target is $200.40How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' CME stock price predictions in the hope that they will be met as they may be wrong and not met. We detected 14 price targets for CME stock released in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-5||UBS Group||Raises Target||$191.00||$214.00||12%|
|2019-8-9||Deutsche Bank||Raises Target||$224.00||$240.00||7.1%|
|2019-7-3||Wells Fargo & Co||Reiterates||$176.00||$200.00||13.6%|
|2019-7-3||Wells Fargo & Co||Raises Target||$176.00||$200.00||13.6%|
|2019-7-3||UBS Group||Raises Target||$190.00||$194.00||2.1%|
|2019-6-5||UBS Group||Raises Target||$175.00||$190.00||8.6%|
|2019-5-2||UBS Group||Lowers Target||$179.00||$175.00||-2.2%|
|2019-5-2||Citigroup||Set Price Target||n/a||$202.00||-|
|2019-3-22||JPMorgan Chase & Co.||Lowers Target||$164.00||$150.00||-8.5%|
|2019-3-15||Deutsche Bank||Lowers Target||$220.00||$214.00||-2.7%|
|2019-2-15||Sanford C. Bernstein||Reiterates||n/a||$210.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, CME was in line with the forecasts of the experts and reported an EPS of $1.77 per share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw an astounding growth of 18.24% to $4,309.40 million dollars. Instead, its earnings margin (compared to sales) collapsed to 45.53%, that is $1,962.20 million.
|2013||$2,930 M||-||$977 M33.3%||-|
|2014||$3,113 M||6.23%||$1,127 M36.2%||15.39%|
|2015||$3,327 M||6.89%||$1,247 M37.5%||10.64%|
|2016||$3,595 M||8.07%||$1,534 M42.7%||23.02%|
|2017||$3,645 M||1.38%||$4,063 M111.5%||164.87%|
|2018||$4,309 M||18.24%||$1,962 M45.5%||-51.71%|
Quarterly financial resultsCME posted $1,236.60 million in revenues for 2018-Q4, a 36.76% improvement compared to previous quarter. Reported quarter income marked $385.50 M with a profit margin of 31.17%. Profit margin plummed a -14.37% compared to previous quarter when profit margin was 45.54%. When comparing revenues to same quarter last year, CME sales marked an outstanding gain and climbed a 37.40%.
|2017-Q2||$925 M||-||$416 M45.0%||-|
|2017-Q3||$891 M||-3.66%||$309 M34.6%||-25.78%|
|2017-Q4||$900 M||1.03%||$2,939 M326.6%||852.43%|
|2018-Q1||$1,109 M||23.22%||$599 M54.0%||-79.63%|
|2018-Q2||$1,060 M||-4.45%||$566 M53.4%||-5.46%|
|2018-Q3||$904 M||-14.67%||$412 M45.5%||-27.26%|
|2018-Q4||$1,237 M||36.76%||$386 M31.2%||-6.39%|
|2019-Q1||$1,180 M||-4.61%||$497 M42.1%||28.90%|
CME ownershipWhen you are planning to invest in a company, it's worth to have a look its ownership structure.
CME shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 1.64% of all shares.
Bearish positions for CME stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to CME:
|Market cap||$75.6 B||$13.0 B||$0.0 M||$52.4 B||$12.9 B|
|Total shares||358.1 M||111.7 M||0.0 M||560.4 M||37.8 M|
|Float shares||349.0 M||110.5 M||0.0 M||553.8 M||36.4 M|
|- Institutional holdings (%)||87.9%||83.2%||0.0%||0.0%||106.0%|
|- Insider holdings (%)||1.6%||0.9%||0.0%||93.2%||2.6%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, September 20th, 2019|
|Day range||$209.78 - $212.89|
|Average true range||$5.27|
|50d mov avg||$209.00|
|100d mov avg||$199.89|
|200d mov avg||$187.79|
CME performanceTo better understand CME performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare CME to Cboe Global Markets, Interactive Brokers, Intercontinental Exchange, MarketAxess, MSCI and Nasdaq:
|CBOECboe Global Marke...||9.51%||22.48%||9.78%|
CME competitorsOne check before trading any stock is to review a list of its competitors, in this case for CME. We picked 6 companies as CME competitors as they are in the same industry or have similar market objectives.
- Cboe Global Markets (CBOE)
- Interactive Brokers (IBKR)
- Intercontinental Exchange (ICE)
- MarketAxess (MKTX)
- MSCI (MSCI)
- Nasdaq (NDAQ)
Latest CME stock news
- Seeking AlphaCME Group: More Growth, But It's A Little ExpensiveMarch 19, 2019
- Seeking AlphaCME: Stock Is Not Cheap, But Will Benefit From Higher Interest Rates And Rate VolatilityOctober 8, 2018
- InvestorPlaceDon’t Be Fooled by the Recent Surge of CME StockOctober 8, 2018
- InvestorPlaceTrade of the Day: CME Group Inc (CME)June 15, 2018